Clinical trial
Thymic Tolerance in Pediatric Heart Transplantation
NCT00151164 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Terminated
Key facts
| NCT number | NCT00151164 |
|---|---|
| Title | Thymic Tolerance in Pediatric Heart Transplantation |
| Official title | Thymic Tolerance in Pediatric Heart Transplantation |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Collaborators | University of Pittsburgh |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heart Transplantation |
| Intervention type | Procedure |
| Interventions | donor bone marrow cell injection into thymus gland |
| Enrollment | 48 |
| Start date | Apr 1, 2004 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Sep 8, 2005 |
| Last update posted | Jul 12, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: